Niklas Savander assumes role as Elekta’s new President and CEO

        Print
| Source: Elekta AB
STOCKHOLM, Sweden, May 1 – As announced in October
2013 (http://www.elekta.com/pressreleases/821813/elekta-appoints-niklas-savander
-as-its-next-president-and-chief-executive-officer.html), Niklas Savander will
today assume the role as Elekta’s President and CEO, succeeding Tomas Puusepp
who will continue as member of the company’s Board of Directors.
Niklas Savander says: “Tomas Puusepp has done a marvelous job and managed to
bring out the best in people at Elekta. At Elekta we always put our customers
and their patients in focus in everything we do. I am proud to take the helm of
this successful and exciting company.”

Niklas Savander will present Elekta’s results for the fourth quarter and the
full fiscal year on May 28; on June 17 a Capital Markets Day will be held in
Stockholm.

# # #

For further information, please contact:
Gert van Santen, Group Vice President Corporate Communications, Elekta AB
Tel: +31 653 561 242, e-mail: gert.vansanten@elekta.com
Time zone: CET: Central European Time
Johan Andersson, Director, Investor Relations, Elekta AB
Tel: +46 702 100 451, e-mail: johan.andersson@elekta.com
Time zone: CET: Central European Time
The above information is such that Elekta AB (publ) shall make public in
accordance with the Securities Market Act and/or the Financial Instruments
Trading Act. The information was published at 07:30 CET on May 1, 2014.
About Elekta
Elekta is a human care company pioneering significant innovations and clinical
solutions for treating cancer and brain disorders. The company develops
sophisticated, state-of-the-art tools and treatment planning systems for
radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing
software systems across the spectrum of cancer care. Stretching the boundaries
of science and technology, providing intelligent and resource-efficient
solutions that offer confidence to both health care providers and patients,
Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000
hospitals worldwide. Elekta employs around 3,500 employees globally. The
corporate headquarters is located in Stockholm, Sweden, and the company is
listed on the Nordic Exchange under the ticker STO:EKTAB. Website:
www.elekta.com.